Seven facts and five initiatives for gut microbiome research

References

[1] Aagaard K, Hohmann E (2019) Regulating microbiome manipulation. Nat Med 25(6):874–876

[2] Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 15 (12):1257–1272

[3] Avetisyan M, Schill EM, Heuckeroth RO (2015) Building a second brain in the bowel. J Clin Invest 125(3):899–907

[4] Bai D, Yip BHK, Windham GC, Sourander A, Francis R, Yoffe R, Glasson E, Mahjani B, Suominen A, Leonard H (2019) Association of genetic and environmental factors with autism in a 5-country cohort. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2019.1411

[5] Barnard ND, Willett WC, Ding EL (2017) The misuse of metaanalysis in nutrition research. JAMA 318(15):1435–1436

[6] Belkaid Y, Harrison OJ (2017) Homeostatic immunity and the microbiota. Immunity 46(4):562–576

[7] Bothwell LE, Podolsky SH (2016) The emergence of the randomized, controlled trial. N Engl J Med 375(6):501–504

[8] Bunyavanich S (2019) Food allergy: could the gut microbiota hold the key? Nat Rev Gastroenterol Hepatol 16(4):201–202

[9] Byndloss MX, Bäumler AJ (2018) The germ-organ theory of noncommunicable diseases. Nat Rev Microbiol 16(2):103–110

[10] Canfora EE, Meex RCR, Venema K, Blaak EE (2019) Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol 15 (5):261–273

[11] Chatterjee S, Khunti K, Davies MJ (2017) Type 2 diabetes. Lancet Lond Engl 389(10085):2239–2251

[12] Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148 (6):1258–1270

[13] Clemente JC, Manasson J, Scher JU (2018) The role of the gut microbiome in systemic inflammatory disease. BMJ 360:j5145

[14] Cohen PA (2018) Probiotic safety-no guarantees. JAMA Intern Med 178(12):1577–1578

[15] Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, Tramontano M, Driessen M, Hercog R, Jung F-E (2017) Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol 35(11):1069–1076

[16] Crow D (2018) Microbiome research in a social world. Cell 172 (6):1143–1145

[17] Cryan JF, O’Riordan KJ, Sandhu K, Peterson V, Dinan TG (2020) The gut microbiome in neurological disorders. Lancet Neurol 19 (2):179–194

[18] Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol 16(8):461–478

[19] Dauby N (2017) Risks of Saccharomyces boulardii-containing probiotics for the prevention of clostridium difficile infection in the elderly. Gastroenterology 153(5):1450–1451

[20] DeFilipp Z, Bloom PP, Torres Soto M, Mansour MK, Sater MRA, Huntley MH, Turbett S, Chung RT, Chen Y-B, Hohmann EL (2019) Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med 381(21):2043–2050

[21] Djulbegovic B, Guyatt GH (2017) Progress in evidence-based medicine: a quarter century on. Lancet Lond Engl 390 (10092):415–423

[22] Dominguez-Bello MG, Peterson D, Noya-Alarcon O, Bevilacqua M, Rojas N, Rodríguez R, Pinto SA, Baallow R, Caballero-Arias H (2016) Ethics of exploring the microbiome of native peoples. Nat Microbiol 1(7):16097

[23] Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, White RC, Clarke TH, Nguyen K, Torralba M(2019) Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature 575(7783):505–511

[24] Fischbach MA (2018) Microbiome: focus on causation and mechanism. Cell 174(4):785–790

[25] Ford AC, Lacy BE, Talley NJ (2017) Irritable bowel syndrome. N Engl J Med 376(26):2566–2578

[26] Franks PW, McCarthy MI (2016) Exposing the exposures responsible for type 2 diabetes and obesity. Science 354(6308):69–73

[27] Galea S, Saitz R (2017) Funding, institutional conflicts of interest, and schools of public health: realities and solutions. JAMA 317 (17):1735–1736

[28] Garrett WS (2015) Cancer and the microbiota. Science 348 (6230):80–86

[29] Gehrig JL, Venkatesh S, Chang H-W, Hibberd MC, Kung VL, Cheng J,Chen RY, Subramanian S, Cowardin CA, Meier MF (2019) Effects of microbiota-directed foods in gnotobiotic animals and undernourished children. Science 365(6449):eaau4732

[30] Gentile CL, Weir TL (2018) The gut microbiota at the intersection of diet and human health. Science 362(6416):776–780

[31] Gilbert JA, Quinn RA, Debelius J,Xu ZZ, Morton J, Garg N, Jansson JK, Dorrestein PC, Knight R (2016) Microbiome-wide association studies link dynamic microbial consortia to disease. Nature 535 (7610):94–103

[32] Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R (2018) Current understanding of the human microbiome. Nat Med 24(4):392–400

[33] Goldszmid RS, Trinchieri G (2012) The price of immunity. Nat Immunol 13(10):932–938

[34] Green JM, Barratt MJ, Kinch M, Gordon JI (2017) Food and microbiota in the FDA regulatory framework. Science 357 (6346):39–40

[35] Greenhalgh S (2019) Making China safe for coke: how Coca-Cola shaped obesity science and policy in China. BMJ 364:k5050

[36] Gribble FM, Reimann F (2019) Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinol 15(4):226–237

[37] Guarino A, Canani RB (2016) Probiotics in childhood diseases: from basic science to guidelines in 20 years of research and development. J Pediatr Gastroenterol Nutr 63(Suppl 1):S1–S2

[38] Hall AB, Tolonen AC, Xavier RJ (2017) Human genetic variation and the gut microbiome in disease. Nat Rev Genet 18(11):690–699

[39] Hanage WP (2014) Microbiology: microbiome science needs a healthy dose of scepticism. Nature 512(7514):247–248

[40] Hoffmann D, Palumbo F, Ravel J, Roghmann M-C, Rowthorn V, von Rosenvinge E (2017) Improving regulation of microbiota transplants . Science 358(6369):1390–1391

[41] Hughes HK, Landa MM, Sharfstein JM (2017) Marketing claims for infant formula: the need for evidence. JAMA Pediatr 171(2):105–106

[42] Inamo J (2019) Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study. Ann Rheum Dis.https://doi.org/10.1136/annrheumdis-2019-216565

[43] Isabella VM, Ha BN, Castillo MJ, Lubkowicz DJ, Rowe SE, Millet YA, Anderson CL, Li N, Fisher AB, West KA (2018) Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat Biotechnol 36(9):857–864

[44] Iweala OI, Nagler CR (2019) The microbiome and food allergy. Annu Rev Immunol 37:377–403

[45] Jia J, Dou P, Gao M, Kong X, Li C, Liu Z, Huang T (2019) Assessment of causal direction between gut microbiota-dependent metabolites and cardiometabolic health: a bidirectional mendelian randomization analysis. Diabetes 68(9):1747–1755

[46] Johnson AJ, Vangay P, Al-Ghalith GA,Hillmann BM, Ward TL, Shields-Cutler RR, Kim AD, Shmagel AK, Syed AN, Personalized Microbiome Class Students (2019) Daily sampling reveals personalized diet-microbiome associations in humans. Cell Host Microbe 25(6):789–802.e5

[47] Keith SW, Redden DT, Katzmarzyk PT, Boggiano MM, Hanlon EC, Benca RM, Ruden D, Pietrobelli A, Barger JL, Fontaine KR (2006) Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes 2005 30(11):1585–1594

[48] Kivipelto M, Mangialasche F, Ngandu T (2018) Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol 14(11):653–666

[49] Kleerebezem M, Binda S, Bron PA, Gross G, Hill C, van Hylckama Vlieg JE, Lebeer S, Satokari R, Ouwehand AC (2019) Understanding mode of action can drive the translational pipeline towards more reliable health benefits for probiotics. Curr Opin Biotechnol 56:55–60

[50] Knight R, Vrbanac A, Taylor BC, Aksenov A, Callewaert C, Debelius J,Gonzalez A, Kosciolek T,McCall L-I, McDonald D(2018) Best practices for analysing microbiomes. Nat Rev Microbiol 16 (7):410–422

[51] Komaroff AL (2017) The microbiome and risk for obesity and diabetes. JAMA 317(4):355–356

[52] Lagier J-C, Dubourg G, Million M, Cadoret F, Bilen M, Fenollar F, Levasseur A, Rolain J-M, Fournier P-E,Raoult D (2018) Culturing the human microbiota and culturomics. Nat Rev Microbiol 16 (9):540–550

[53] Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto J-M,Kennedy S (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500(7464):541–546

[54] Levin ME, Botha M, Basera W,Facey-Thomas HE, Gaunt B, Gray CL, Kiragu W, Ramjith J, Watkins A, Genuneit J (2020) Environmental factors associated with allergy in urban and rural children from the South AFrican Food Allergy (SAFFA) cohort. J Allergy Clin Immunol 145(1):415–426

[55] Lloyd-Price J, Abu-Ali G, Huttenhower C (2016) The healthy human microbiome. Genome Med 8(1):51

[56] Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375(24):2369–2379

[57] Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, Costa FRC, Tiniakou E, Greiling T,Ruff W (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359(6380):1156–1161

[58] Mayer EA (2011) Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 12(8):453–466

[59] Meisel M, Hinterleitner R, Pacis A, Chen L, Earley ZM, Mayassi T, Pierre JF, Ernest JD, Galipeau HJ, Thuille N (2018) Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557(7706):580–584

[60] Miller V,Mente A, Dehghan M, Rangarajan S, Zhang X, Swaminathan S, Dagenais G,Gupta R, Mohan V, Lear S (2017) Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Lancet Lond Engl 390(10107):2037–2049

[61] Mitselou N, Hallberg J, Stephansson O, Almqvist C, Melén E,Ludvigsson JF (2018) Cesarean delivery, preterm birth, and risk of food allergy: nationwide Swedish cohort study of more than 1 million children. J Allergy Clin Immunol 142(5):1510–1514.e2

[62] Mozaffarian D (2017) Conflict of interest and the role of the food industry in nutrition research. JAMA 317(17):1755–1756

[63] Nayfach S, Shi ZJ, Seshadri R, Pollard KS, Kyrpides NC (2019) New insights from uncultivated genomes of the global human gut microbiome. Nature 568(7753):505–510

[64] Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S (2012) Host-gut microbiota metabolic interactions. Science 336(6086):1262–1267

[65] NIH Human Microbiome Portfolio Analysis Team (2019) A review of 10 years of human microbiome research activities at the US National Institutes of Health, Fiscal Years 2007–2016. Microbiome 7(1):31

[66] Nissen SE (2017) Conflicts of interest and professional medical associations: progress and remaining challenges. JAMA 317 (17):1737–1738

[67] O’Doherty KC, Virani A, Wilcox ES (2016) The human microbiome and public health: social and ethical considerations. Am J Public Health 106(3):414–420

[68] O’Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7(7):688–693

[69] Pararajasingam A, Uwagwu J (2017) Lactobacillus: the not so friendly bacteria. BMJ Case Rep 2017:bcr-2016-218423

[70] Pennisi E (2017) Survey of archaea in the body reveals other microbial guests. Science 358(6366):983

[71] Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S (2019) Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology 157(3):647–659.e4

[72] Poussin C, Sierro N, Boué S, Battey J, Scotti E, Belcastro V, Peitsch MC, Ivanov NV, Hoeng J (2018) Interrogating the microbiome: experimental and computational considerations in support of study reproducibility. Drug Discov Today 23(9):1644–1657

[73] Proctor L (2019) Priorities for the next 10 years of human microbiome research. Nature 569(7758):623–625

[74] Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55–60

[75] Quince C, Walker AW, Simpson JT, Loman NJ, Segata N (2017) Shotgun metagenomics, from sampling to analysis. Nat Biotechnol 35(9):833–844

[76] Rastelli M, Cani PD, Knauf C (2019) The gut microbiome influences host endocrine functions. Endocr Rev 40(5):1271–1284

[77] Rehfeld JF (1998) The new biology of gastrointestinal hormones. Physiol Rev 78(4):1087–1108

[78] Reynolds LA, Finlay BB (2017) Early life factors that affect allergy development. Nat Rev Immunol 17(8):518–528

[79] Rhodes R (2016) Ethical issues in microbiome research and medicine. BMC Med 14(1):156

[80] Richard ML, Sokol H (2019) The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases. Nat Rev Gastroenterol Hepatol 16(6):331–345

[81] Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science . 341(6150):1241214

[82] Rooks MG, Garrett WS (2016) Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16(6):341–352

[83] Rosshart SP, Herz J, Vassallo BG, Hunter A, Wall MK, Badger JH, McCulloch JA, Anastasakis DG, Sarshad AA, Leonardi I (2019) Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science 365(6452): eaaw4361

[84] Schiattarella GG, Sannino A, Toscano E, Giugliano G, Gargiulo G, Franzone A, Trimarco B, Esposito G, Perrino C (2017) Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis. Eur Heart J 38(39):2948–2956

[85] Schloss PD (2018) Identifying and overcoming threats to reproducibility, replicability, robustness, and generalizability in microbiome research. mBio 9(3):e00525–18

[86] Schmidt TSB, Raes J, Bork P (2018) The human gut microbiome: from association to modulation. Cell 172(6):1198–1215

[87] Schroeder BO, Bäckhed F (2016) Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 22(10):1079–1089

[88] Scott AJ, Alexander JL, Merrifield CA, Cunningham D, Jobin C, Brown R, Alverdy J, O’Keefe SJ, Gaskins HR, Teare J (2019) International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis. Gut 68(9):1624–1632

[89] Sekirov I,Russell SL, Antunes LCM, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90(3):859–904

[90] Servick K (2016) Of mice and microbes. Science 353(6301):741–743

[91] Shamarina D, Stoyantcheva I, Mason CE, Bibby K, Elhaik E (2017) Communicating the promise, risks, and ethics of large-scale, open space microbiome and metagenome research. Microbiome 5(1):132

[92] Shanahan F, Hill C (2019) Language, numeracy and logic in microbiome science. Nat Rev Gastroenterol Hepatol 16(7):387–388

[93] Sharon G, Sampson TR, Geschwind DH, Mazmanian SK (2016) The central nervous system and the gut microbiome. Cell 167(4):915–932

[94] Shendure J, Balasubramanian S, Church GM, Gilbert W, Rogers J, Schloss JA, Waterston RH (2017) DNA sequencing at 40: past, present and future. Nature 550(7676):345–353

[95] Shkoporov AN, Hill C (2019) Bacteriophages of the human gut: the “known unknown” of the microbiome. Cell Host Microbe 25 (2):195–209

[96] Singh P, Mitsuhashi S, Ballou S, Rangan V, Sommers T, Cheng V,Iturrino-Moreda J, Friedlander D, Nee J, Lembo A (2018a) Demographic and dietary associations of chronic diarrhea in a representative sample of adults in the United States. Am J Gastroenterol 113(4):593–600

[97] Singh V, Yeoh BS, Chassaing B, Xiao X, Saha P, Aguilera Olvera R, Lapek JD, Zhang L, Wang W-B, Hao S (2018b) Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer. Cell 175(3):679–694.e22

[98] Skelly AN, Sato Y, Kearney S, Honda K (2019) Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol 19(5):305–323

[99] Sox HC (2017) Conflict of interest in practice guidelines panels. JAMA 317(17):1739–1740

[100] Stead WW (2017) The complex and multifaceted aspects of conflicts of interest. JAMA 317(17):1765–1767

[101] Suez J, Zmora N, Zilberman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, Zur M, Regev-Lehavi D, Ben-Zeev Brik R, Federici S (2018) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell 174(6):1406–1423.e16

[102] The Lancet null (2019) Dietary supplement regulation: FDA’s bitter pill. Lancet Lond Engl 393(10173):718

[103] Thornton JP (2017) Conflict of interest and legal issues for investigators and authors. JAMA 317(17):1761–1762

[104] Tilg H, Zmora N, Adolph TE, Elinav E (2020) The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol 20 (1):40–54

[105] Tordesillas L, Berin MC, Sampson HA (2017) Immunology of food allergy. Immunity 47(1):32–50

[106] Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027–1031

[107] Untangle food industry influences on health (2019) Nat Med 25 (11):1629

[108] Uzbay T (2019) Germ-free animal experiments in the gut microbiota studies. Curr Opin Pharmacol 49:6–10

[109] Vaughn BP, Rank KM, Khoruts A (2019) Fecal microbiota transplantation: current status in treatment of gi and liver disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 17(2):353–361

[110] Verbeke F, Janssens Y, Wynendaele E, De Spiegeleer B (2017) Faecal microbiota transplantation: a regulatory hurdle? BMC Gastroenterol 17(1):128

[111] Vitiello GA, Cohen DJ, Miller G (2019) Harnessing the microbiome for pancreatic cancer immunotherapy. Trends Cancer 5(11):670–676

[112] Weiner HL, da Cunha AP, Quintana F, Wu H (2011) Oral tolerance. Immunol Rev 241(1):241–259

[113] Wong SH, Yu J (2019) Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol 16(11):690–704

[114] Yelin I, Flett KB, Merakou C, Mehrotra P, Stam J, Snesrud E, Hinkle M, Lesho E, McGann P, McAdam AJ (2019) Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med 25(11):1728–1732

[115] Yoo BB, Mazmanian SK (2017) The enteric network: interactions between the immune and nervous systems of the gut. Immunity 46(6):910–926

[116] Yu L-X, Schwabe RF (2017) The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol 14(9):527–539

[117] Yuan J, Chen C,Cui J, Lu J, Yan C,Wei X, Zhao X,Li N, Li S, Xue G et al (2019) Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab 30(6):1172

[118] Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M (2015) Personalized nutrition by prediction of glycemic responses. Cell 163(5):1079–1094

[119] Zeilstra D, Younes JA, Brummer RJ, Kleerebezem M (2018) Perspective: fundamental limitations of the randomized controlled trial method in nutritional research: the example of probiotics. Adv Nutr Bethesda Md 9(5):561–571

[120] Zhang X, Li L, Butcher J, Stintzi A, Figeys D (2019) Advancing functional and translational microbiome research using metaomics approaches. Microbiome 7(1):154

[121] Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J et al (2018) Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359(6380):1151–1156

[122] Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL (2019a) Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science 363(6427):eaat9931

[123] Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL (2019b) Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570(7762):462–467

[124] Zmora N, Zeevi D, Korem T, Segal E, Elinav E (2016) Taking it personally: personalized utilization of the human microbiome in health and disease. Cell Host Microbe 19(1):12–20

[125] Zuger A (2017) What do patients think about physicians’ conflicts of interest?: watching transparency evolve. JAMA 317(17):1747–1748

RIGHTS & PERMISSIONS

2020 The Author(s)